261 related articles for article (PubMed ID: 15592503)
61. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
Niu G; Heller R; Catlett-Falcone R; Coppola D; Jaroszeski M; Dalton W; Jove R; Yu H
Cancer Res; 1999 Oct; 59(20):5059-63. PubMed ID: 10537273
[TBL] [Abstract][Full Text] [Related]
62. Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.
Rahaman SO; Vogelbaum MA; Haque SJ
Cancer Res; 2005 Apr; 65(7):2956-63. PubMed ID: 15805299
[TBL] [Abstract][Full Text] [Related]
63. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
Tang C; Xue HL; Huang HB; Wang XG
Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
[TBL] [Abstract][Full Text] [Related]
64. STAT proteins: from normal control of cellular events to tumorigenesis.
Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
[TBL] [Abstract][Full Text] [Related]
65. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
[TBL] [Abstract][Full Text] [Related]
66. VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma.
Chen H; Ye D; Xie X; Chen B; Lu W
Gynecol Oncol; 2004 Sep; 94(3):630-5. PubMed ID: 15350351
[TBL] [Abstract][Full Text] [Related]
67. Combined targeting of epidermal growth factor receptor, signal transducer and activator of transcription-3, and Bcl-X(L) enhances antitumor effects in squamous cell carcinoma of the head and neck.
Boehm AL; Sen M; Seethala R; Gooding WE; Freilino M; Wong SM; Wang S; Johnson DE; Grandis JR
Mol Pharmacol; 2008 Jun; 73(6):1632-42. PubMed ID: 18326051
[TBL] [Abstract][Full Text] [Related]
68. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
Li GH; Wei H; Lv SQ; Ji H; Wang DL
Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
[TBL] [Abstract][Full Text] [Related]
69. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
[TBL] [Abstract][Full Text] [Related]
70. STAT3 activation is required for Asp(816) mutant c-Kit induced tumorigenicity.
Ning ZQ; Li J; McGuinness M; Arceci RJ
Oncogene; 2001 Jul; 20(33):4528-36. PubMed ID: 11494148
[TBL] [Abstract][Full Text] [Related]
71. Bacterial N-acylhomoserine lactone-induced apoptosis in breast carcinoma cells correlated with down-modulation of STAT3.
Li L; Hooi D; Chhabra SR; Pritchard D; Shaw PE
Oncogene; 2004 Jun; 23(28):4894-902. PubMed ID: 15064716
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
73. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I
Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470
[TBL] [Abstract][Full Text] [Related]
74. Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis.
Nagpal JK; Mishra R; Das BR
Cancer; 2002 May; 94(9):2393-400. PubMed ID: 12015764
[TBL] [Abstract][Full Text] [Related]
75. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model.
Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K
Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842
[TBL] [Abstract][Full Text] [Related]
76. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
77. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo.
Grandis JR; Drenning SD; Zeng Q; Watkins SC; Melhem MF; Endo S; Johnson DE; Huang L; He Y; Kim JD
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4227-32. PubMed ID: 10760290
[TBL] [Abstract][Full Text] [Related]
78. STAT3 is involved in esophageal carcinogenesis through regulation of Oct-1.
Wang Z; Zhu S; Shen M; Liu J; Wang M; Li C; Wang Y; Deng A; Mei Q
Carcinogenesis; 2013 Mar; 34(3):678-88. PubMed ID: 23172665
[TBL] [Abstract][Full Text] [Related]
79. STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.
Joo A; Aburatani H; Morii E; Iba H; Yoshimura A
Oncogene; 2004 Jan; 23(3):726-34. PubMed ID: 14737107
[TBL] [Abstract][Full Text] [Related]
80. Constitutive activation of Stat3 correlates with increased expression of the c-Met/HGF receptor in oral squamous cell carcinoma.
Klosek SK; Nakashiro K; Hara S; Li C; Shintani S; Hamakawa H
Oncol Rep; 2004 Aug; 12(2):293-6. PubMed ID: 15254691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
